Latent membrane protein-1 oncogene deletions in nasopharyngeal carcinoma in Caucasian patients

Acta Oto-Laryngologica

Volumn 123, Issue 5, 2003, Pages 664-668

  Plaza, Guillermo ^a   Santón, Almudena ^b   Vidal, Antonio Martínez ^b   Bellas, Carmen ^b  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Caucasian patients; Epstein Barr virus; Latent membrane protein 1 oncogene deletion; Nasopharyngeal carcinoma; Polymerase chain reaction

Indexed keywords

EOSIN; FORMALDEHYDE; HEMATOXYLIN; LATENT MEMBRANE PROTEIN 1; PARAFFIN; RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NASOPHARYNX CARCINOMA; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; VIRUS GENE;

EID: 0038235976     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480310000593     Document Type: Article

References (27)

1. Vasef MA, Ferlito A, Weiss LM. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus. Ann Otol Rhinol Laryngol 1997; 106: 348-56.
2. Vera-Sempere FJ, Burgos JS, Botella MS, Cordoba J. Comparative analysis of Epstein-Barr virus (EBV) detection by nested-PCR and non-isotopic in situ hybridization in nasopharyngeal carcinoma. Clin Chim Acta 1998; 271: 119-32.
3. Plaza G, Santón A, Manzanal AI, Martínez-Montero JC, Bellas C. Association of Epstein-Barr virus to nasopharyngeal carcinoma in Caucasian patients. Ann Otol Rhinol Laryngol 2002; 111: 210-6.
4. Carbone A, Dolcetti R, Shaha AR, et al. What's new in the biology and treatment of undifferentiated carcinoma of nasopharyngeal type? Acta Otolaryngol 2001; 121: 884-95.
5. Hu L-F, Zabarovsky ER, Chen F, et al. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinoma. Eur J Cancer 1995; 31A: 658-60.
6. Hu LF, Zabarovsky ER, Chen F, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991; 72: 2399-409.
7. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlation with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242-51.
8. Cheung ST, Lo KW, Leung SF, et al. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in HongKong [Letter]. Int J Cancer 1996; 66: 711-2.
9. Chang Y-S, Su I-J, Shu C-H, Ng C-K, Wu S-J, Liu S-T. Detection of an Epstein-Barr virus variant in T-cell lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int J Cancer 1995; 62: 673-7.
10. Chen W-G, Chen Y-Y, Bacchi M-M, Bacchi CE, Alvarenga M, Weiss LE. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 1996; 148: 17-23.
11. Itakura O, Yamada S, Narita M, Kikuta H. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP-1 oncogene of Epstein-Barr virus in the Japanese population. Oncogene 1996; 13: 1549-53.
12. Dolcetti R, Zancai P, De Re V, et al. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 1997; 89: 1723-31.
13. Knecht H, Raphaël M, McQuain C, et al. Deletion variants within the NF-κB activation domain of the LMP-1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 1996; 87: 876-81.
14. Bellas C, Santón A, Manzanal A, et al. Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection: comparison with ordinary Hodgkin's disease. Am J Surg Pathol 1996; 20: 1520-4.
15. Santón A, Martin C, Manzanal AI, Preciado MV, Bellas C. Pediatric Hodgkin's disease in Spain: association with Epstein-Barr virus strains carrying latent membrane protein-1 oncogene deletions and high frequency of dual infections. B J Haematol 1998; 103: 129-36.
16. Plaza G. Coinfection by multiple strains of Epstein-Barr virus in infectious mononucleosis in immunocompetent patients. Acta Otolaryngol 2003; 123: 000-000.
17. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx: variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995; 146: 1355-67.
18. Horikawa T, Sheen TS, Takeshita H, Sato H, Furukawa M, Yoshizaki T. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am J Pathol 2001; 159: 27-33.
19. Yoshizaki T, Horikawa T, Qing-Chun R, et al. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma. Clin Cancer Res 2001; 7: 1946-51.
20. Horikawa T, Yoshizaki T, Sheen TS, Lee SY, Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 2000; 89: 715-23.
21. Lin SY, Tsang NM, Kao SC, et al. Presence of Epstein-Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma. Head Neck 2001; 23: 194-200.
22. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Clonal proliferation of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995; 333: 693-8.
23. Santon A, Bellas C. Deletions within the Epstein-Barr virus latent membrane protein-1 oncogene in adult ordinary, HIV-associated and paediatric Hodgkin's disease. Leuk Lymphoma 2001; 40: 235-42.
24. Leung SY, Yuen ST, Chung LP, Chan ASY, Wong MP. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non nasopharyngeal EBV-associated carcinomas in Hong Kong chinese. Int J Cancer 1997; 72: 225-30.
25. Smir BN, Hauke RJ, Bierman PJ, et al. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in postransplant lymphoproliferative disorders. Lab Invest 1996; 75: 575-88.
26. Sandvej K, Gratama JW, Munch M, et al. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 1997; 90: 323-30.
27. Srivastava G, Wong KY, Chiang AKS, Lam KY, Tao Q. Coinfection by multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood 2000; 95: 2443-5.